日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pan-cancer analysis of RNA expression signatures associated with cancer tissue architecture

对与癌组织结构相关的RNA表达特征进行泛癌分析

Mogi, Megumi; Kawase, Katsushige; Tanaka, Hiroyoshi Y; Miyata, Suguru; Takemoto, Satoko; Ikeda, Hideki; Katayama, Eri; Nakamura, Yuki; Kojima, Ryuta; Morinaga, Takao; Tanabe, Shihori; Yonekura, Syuji; Kano, Mitsunobu R; Hanazawa, Toyoyuki; Kawazu, Masahito

The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系

Kanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Tsuchiya, Takahiro; Fujiya, Makoto; Sawada, Midori; Izai, Ryo; Akatsuka, Teppei; Miwa, Chihiro; Yonemoto, Takuya; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Takano, Yuka; Takata, Kaho; Lin, Jason; Kawazu, Masahito; Ikeda, Jun-Ichiro; Ohtsuka, Masayuki; Hoshida, Yujin; Komuta, Mina; Togashi, Yosuke

Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profiling

利用 miRNA-mRNA 整合分析法研究早期胃腺癌患者异时性复发的危险因素

Nagashima, Ariki; Okimoto, Kenichiro; Nakagawa, Ryo; Akizue, Naoki; Matsumura, Tomoaki; Oura, Hirotaka; Kojima, Ryuta; Goto, Chihiro; Takahashi, Satsuki; Horio, Ryosuke; Kurosugi, Akane; Ishikawa, Tsubasa; Shiratori, Wataru; Kaneko, Tatsuya; Kanayama, Kengo; Ohta, Yuki; Taida, Takashi; Saito, Keiko; Chiba, Tetsuhiro; Kato, Jun; Kato, Naoya

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

在真实世界中,雷莫芦单抗被用于晚期肝细胞癌患者的多种治疗方案

Kanogawa, Naoya; Ogasawara, Sadahisa; Maruta, Susumu; Iino, Yotaro; Obu, Masamichi; Ishino, Takamasa; Ogawa, Keita; Yumita, Sae; Iwanaga, Terunao; Unozawa, Hidemi; Nakagawa, Miyuki; Fujiwara, Kisako; Sakuma, Takafumi; Fujita, Naoto; Kojima, Ryuta; Kanzaki, Hiroaki; Koroki, Keisuke; Kobayashi, Kazufumi; Inoue, Masanori; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Saito, Tomoko; Nakagawa, Ryo; Nakamoto, Shingo; Muroyama, Ryosuke; Chiba, Tetsuhiro; Itobayashi, Ei; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Jun; Kato, Naoya

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

日本真实世界实践中晚期肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗期间出现超进展性疾病的情况

Yumita, Sae; Ogasawara, Sadahisa; Nakagawa, Miyuki; Maruta, Susumu; Okubo, Tomomi; Itokawa, Norio; Iino, Yotaro; Obu, Masamichi; Haga, Yuki; Seki, Atsuyoshi; Kogure, Tadayoshi; Ishino, Takamasa; Ogawa, Keita; Fujiwara, Kisako; Iwanaga, Terunao; Fujita, Naoto; Sakuma, Takafumi; Kojima, Ryuta; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Kondo, Takayuki; Nakagawa, Ryo; Nakamoto, Shingo; Muroyama, Ryosuke; Chiba, Tetsuhiro; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Ito, Kenji; Mizumoto, Hideaki; Kato, Jun; Kato, Naoya

Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis

卡博替尼治疗晚期肝细胞癌的最新真实世界实践:一项多中心回顾性分析

Kanzaki, Hiroaki; Ogasawara, Sadahisa; Okubo, Tomomi; Itokawa, Norio; Yoshino, Ryohei; Fujimoto, Kentaro; Kogure, Tadayoshi; Yumita, Sae; Ishino, Takamasa; Ogawa, Keita; Iwanaga, Terunao; Nakagawa, Miyuki; Fujiwara, Kisako; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Nakagawa, Ryo; Nakamoto, Shingo; Muroyama, Ryosuke; Itobayashi, Ei; Atsukawa, Masanori; Kato, Jun; Kato, Naoya

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma

对乙型肝炎病毒整合位点的重新分析揭示了与肝细胞癌发生相关的潜在新位点

Kojima, Ryuta; Nakamoto, Shingo; Kogure, Tadayoshi; Ma, Yaojia; Ogawa, Keita; Iwanaga, Terunao; Qiang, Na; Ao, Junjie; Nakagawa, Ryo; Muroyama, Ryosuke; Nakamura, Masato; Chiba, Tetsuhiro; Kato, Jun; Kato, Naoya

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma.

血清血管生成素 2 可作为肝细胞癌的诊断和预后生物标志物

Ao Junjie, Chiba Tetsuhiro, Kanzaki Hiroaki, Kanayama Kengo, Shibata Shuhei, Kurosugi Akane, Iwanaga Terunao, Kan Motoyasu, Sakuma Takafumi, Qiang Na, Ma Yaojia, Kojima Ryuta, Kusakabe Yuko, Nakamura Masato, Kobayashi Kazufumi, Kiyono Soichiro, Kanogawa Naoya, Saito Tomoko, Nakagawa Ryo, Kondo Takayuki, Ogasawara Sadahisa, Suzuki Eiichiro, Nakamoto Shingo, Muroyama Ryosuke, Tawada Akinobu, Kato Jun, Kanda Tatsuo, Maruyama Hitoshi, Kato Naoya